0001442720-16-000003.txt : 20160203
0001442720-16-000003.hdr.sgml : 20160203
20160203091420
ACCESSION NUMBER: 0001442720-16-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160203
DATE AS OF CHANGE: 20160203
EFFECTIVENESS DATE: 20160203
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: HEMOSHEAR THERAPEUTICS, LLC
CENTRAL INDEX KEY: 0001442720
IRS NUMBER: 261979231
STATE OF INCORPORATION: VA
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-256580
FILM NUMBER: 161383358
BUSINESS ADDRESS:
STREET 1: 501 LOCUST AVENUE
STREET 2: SUITE 301
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
BUSINESS PHONE: 434-872-0196
MAIL ADDRESS:
STREET 1: 501 LOCUST AVENUE
STREET 2: SUITE 301
CITY: CHARLOTTESVILLE
STATE: VA
ZIP: 22902
FORMER COMPANY:
FORMER CONFORMED NAME: HEMOSHEAR LLC
DATE OF NAME CHANGE: 20080812
D
1
primary_doc.xml
X0707
D
LIVE
0001442720
HEMOSHEAR THERAPEUTICS, LLC
501 Locust Avenue
Suite 301
CHARLOTTESVILLE
VA
VIRGINIA
22902
434-872-0196
VIRGINIA
HEMOSHEAR LLC
Limited Liability Company
true
James
C.
Powers
210 10th Street
Apt. 302
Charlottesville
VA
VIRGINIA
22902
Executive Officer
Director
Brian
R.
Wamhoff
826 Village Road
Charlottesville
VA
VIRGINIA
22903
Executive Officer
Nicole
Hastings
1507 Gentry Lane
Charlottesville
VA
VIRGINIA
22903
Executive Officer
Richard
O.
White
2800 Meadow Vista
Charlottesville
VA
VIRGINIA
22901
Executive Officer
John
L.
Brooks, III
3 Tannery Drive
Medfield
MA
MASSACHUSETTS
02052
Director
Robert
Gould
33 Lakeshore Ave.
Beverly
MA
MASSACHUSETTS
01915
Director
Mehmood
A.
Khan
47 Round Hill Road
Greenwich
CT
CONNECTICUT
06831
Director
H.
Thomas
Watkins
785 E. Westminster
Lake Forest
IL
ILLINOIS
60055
Director
Reginald
F.
Woods
4822 Barn Field Drive
Keswick
VA
VIRGINIA
22947
Director
Biotechnology
Decline to Disclose
- 06b
false
true
false
true
false
250000
20000000
0
20000000
An initial closing may occur when the Issuer has raised $2,000,000.
false
0
0
0
0
true
false
HEMOSHEAR THERAPEUTICS, LLC
/James C. Powers/
James C. Powers
CEO
2016-01-29